Oncogenic mutations of ALK kinase in neuroblastoma

Nature

Volumn 455, Issue 7215, 2008, Pages 971-974

  Chen, Yuyan ^a   Takita, Junko ^a   Choi, Young Lim ^b   Kato, Motohiro ^a   Ohira, Miki ^c   Sanada, Masashi ^a,d   Wang, Lili ^a,d   Soda, Manabu ^b   Kikuchi, Akira ^e   Igarashi, Takashi ^a   Nakagawara, Akira ^c   Hayashi, Yasuhide ^f   Mano, Hiroyuki ^b,d   Ogawa, Seishi ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c CHIBA CANCER CENTER   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^f Gumna Children S Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; RNA;

AGAR; CANCER; CHILD HEALTH; COMPARATIVE STUDY; DNA; ENZYME ACTIVITY; GENOME; HETEROZYGOSITY; INHIBITOR; MUTATION; PATHOGENICITY; TUMOR;

ARTICLE; CHILD; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; GENE AMPLIFICATION; GENE LOCUS; GENE MUTATION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

MUS MUSCULUS;

EID: 54049118823     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature07399     Document Type: Article

References (26)

1. Maris, J. M., Hogarty, M. D., Bagatell, R. & Cohn, S. L. Neuroblastoma. Lancet 369, 2106-2120 (2007).
2. Maris, J. M. et al. Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study. J. Clin. Oncol. 18, 1888-1899 (2000).
3. Attiyeh, E. F. et al. Chromosome 1p and 11q deletions and outcome in neuroblastoma. N. Engl. J. Med. 353, 2243-2253 (2005).
4. Bown, N. et al. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N. Engl. J. Med. 340, 1954-1961 (1999).
5. Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E. & Bishop, J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224, 1121-1124 (1984).
6. Shiota, M. et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood 86, 1954-1960 (1995).
7. Morris, S. W. et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263, 1281-1284 (1994).
8. Fujimoto, J. et al. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc. Natl Acad. Sci. USA 93, 4181-4186 (1996).
9. Soda, M. et al. Identification of the transforming EML4-ALK fusion gene in nonsmall-cell lung cancer. Nature 448, 561-566 (2007).
10. Rikova, K. et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131, 1190-1203 (2007).
11. Kennedy, G. C. et al. Large-scale genotyping of complex DNA. Nature Biotechnol. 21, 1233-1237 (2003).
12. Matsuzaki, H. et al. Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nature Methods 1, 109-111 (2004).
13. Nannya, Y. et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res. 65, 6071-6079 (2005).
14. Yamamoto, G. et al. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix singlenucleotide-polymorphism genotyping microarrays. Am. J. Hum. Genet. 81, 114-126 (2007).
15. Osajima-Hakomori, Y. et al. Biological role of anaplastic lymphoma kinase in neuroblastoma. Am. J. Pathol. 167, 213-222 (2005).
16. Donohoe, E. Denaturing high-performance liquid chromatography using the WAVE DNA fragment analysis system. Methods Mol. Med. 108, 173-187 (2005).
17. Hu, J., Liu, J., Ghirlando, R., Saltiel, A. R. & Hubbard, S. R. Structural basis for recruitment of the adaptor protein APS to the activated insulin receptor. Mol. Cell 12, 1379-1389 (2003).
18. Donella-Deana, A. et al. Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity. Biochemistry 44, 8533-8542 (2005).
19. McDermott, U. et al. Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors. Cancer Res. 68, 3389-3395 (2008).
20. Garraway, L. A. et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117-122 (2005).
21. Mullighan, C. G. et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758-764 (2007).
22. Kawamata, N. et al. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood 111, 776-784 (2008).
23. Smith, E. I., Haase, G. M., Seeger, R. C. & Brodeur, G. M. A surgical perspective on the current staging in neuroblastoma-the International Neuroblastoma Staging System proposal. J. Pediatr. Surg. 24, 386-390 (1989).
24. Takita, J. et al. Allelotype of neuroblastoma. Oncogene 11, 1829-1834 (1995).
25. Takita, J. et al. Absent or reduced expression of the caspase 8 gene occurs frequently in neuroblastoma, but not commonly in Ewing sarcoma or rhabdomyosarcoma. Med. Pediatr. Oncol. 35, 541-543 (2000).
26. Takita, J. et al. Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma. Oncogene 20, 4424-4432 (2001).